THE DEAL, AT A GLANCE
From the announcementEpitome Therapeutics
01What it doesEpitome Therapeutics is a Vienna, announced its launch with-based Digital Health company focused on bring significant advancements in gene expression regulation, moving…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by ["XISTA Science Ventures", "Caesar Ventures", "non-dilutive grants"]From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedEpitome Therapeutics raised $4M Pre-Seed, announced 2026-07-04From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersEpitome Therapeutics is using a Pre-Seed financing to advance CADENCE, an epigenome editing platform for gene expression regulation, while moving toward drug candidate…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Epitome Therapeutics · Financing Record
Explore source-linked visual explanations for Epitome Therapeutics. Unsupported claims are withheld while source review continues.
Record 7334 · Recorded date: 2026-07-04
Explore company records →